大象传媒

The team at Durham University are developing a drug that can prevent and reverse damage caused by Motor Neurone Disease.

Andy Whiting from the Nevrargenics team spoke to Amy Oakden as the foundation aims to raise 拢350,000 to get the drug to the stage of human testing, with the aim of public use by the end of this year.